BiophotonicsPlus

Basic Information

Description

This ERANET-PLUS on Biophotonics aims to consolidate the respective funding activities in the participating countries and regions and to achieve the best possible exploitation of the resources and the innovative potential of European industry and science.
This shall be achieved through a joint call primarily focusing on Biophotonics methods and applications that are translatable into products on the short term. On the one hand, already existing biophotonic technology shall be further developed, refined and combined to the stage of pre-commercial demonstrators which should easily be convertible to commercial products. The pre-commercial demonstrator should be used in application fields with a high societal and/or economic relevance for Europe such as medicine (including veterinary medicine), environment, cosmetics, food and drug quality & safety. On the other hand, seed funding shall be provided to promising application-oriented approaches at an early stage of the value chain.
The main activities in the framework of BiophotonicsPlus comprise the preparation of the joint call for proposals, the publication and promotion of the call, the joint evaluation and selection of the proposals and the monitoring of the selected R&D projects.